Adrian Rawcliffe
Chief Executive Officer bei ADAPTIMMUNE THERAPEUTICS PLC
Vermögen: 275 802 $ am 31.03.2024
Profil
Adrian Rawcliffe is currently the Chief Executive Officer & Director at Adaptimmune Therapeutics Plc.
He is also a Director at Morphotek, Inc., an Independent Director at Wave Life Sciences Ltd., and a Director at Wave Life Sciences USA, Inc. Previously, he served as the Chief Financial Officer at Human Genome Sciences, Inc. Mr. Rawcliffe's former positions include Managing Partner at GSK Equity Investments Ltd., Senior Vice President-Finance at GSK Plc, Vice President at GlaxoSmithKline Biologicals NV, and Principal at AlgoRx Pharmaceuticals, Inc. He obtained his undergraduate degree from the University of Durham in 1993.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
17.01.2024 | 888 831 ( 0,16% ) | 234 109 $ | 31.03.2024 | |
12.01.2024 | 26 388 ( 0,01% ) | 41 693 $ | 31.03.2024 | |
WAVE LIFE SCIENCES LTD.
-.--% | 07.08.2023 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Adrian Rawcliffe
Unternehmen | Position | Beginn |
---|---|---|
ADAPTIMMUNE THERAPEUTICS PLC | Chief Executive Officer | 01.09.2019 |
WAVE LIFE SCIENCES LTD. | Director/Board Member | 01.02.2017 |
Morphotek, Inc.
Morphotek, Inc. Miscellaneous Commercial ServicesCommercial Services Morphotek, Inc. operates as a biotechnology company. It develops and distributes biopharmaceutical products. The firm leverages its Morphodoma and Libradoma platform technologies to develop and research a pipeline of preclinical and clinical stage monoclonal antibodies for the treatment of cancer, inflammation and infectious diseases. The company was founded by Nicholas C. Nicolaides, Luigi Grasso and Philip M. Sass in May 2000 and is headquartered in Exton, PA. | Director/Board Member | - |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Director of Finance/CFO | 30.07.2012 |
Wave Life Sciences USA, Inc.
Wave Life Sciences USA, Inc. Electric UtilitiesUtilities Part of Wave Life Sciences Ltd., Wave Life Sciences USA, Inc. is a private company that provides nucleic acid therapeutics. The company is based in Cambridge, MA. The company was founded in 2012 by Gregory L. Verdine, Takeshi Wada. The CEO is Paul B. Bolno. | Director/Board Member | - |
Ehemalige bekannte Positionen von Adrian Rawcliffe
Unternehmen | Position | Ende |
---|---|---|
GSK PLC | Corporate Officer/Principal | 01.01.2015 |
AlgoRx Pharmaceuticals, Inc.
AlgoRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AlgoRx Pharmaceuticals, Inc. was a pharmaceutical company. The company developed and commercialized drugs for pain management. The company was founded in 2001 and was hedquartered in Secaucus, NJ. | Corporate Officer/Principal | 18.02.2009 |
GSK Equity Investments Ltd.
GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity Investment Ltd (GSK Equity) is a venture capital firm a subsidiary of GlaxoSmithKline Plc founded in 1985. The firm is headquartered in Reedwood City, California. | President | 01.01.2006 |
GlaxoSmithKline Biologicals NV
GlaxoSmithKline Biologicals NV BiotechnologyHealth Technology GlaxoSmithKline Biologicals SA manufactures vaccines for diseases such as hepatitis, influenza, rubella, and typhoid fever. Its activities include overall strategy, research and development, clinical trials, regulatory matters, production, quality control, marketing, and distribution. The company has partnership with WHO and UNICEF. GlaxoSmithKline Biologicals was founded in 1945 and is headquartered in Rixensart, Belgium. | Corporate Officer/Principal | 30.04.2005 |
Ausbildung von Adrian Rawcliffe
University of Durham | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
WAVE LIFE SCIENCES LTD. | Health Technology |
GSK PLC | Health Technology |
ADAPTIMMUNE THERAPEUTICS PLC | Health Technology |
Private Unternehmen | 6 |
---|---|
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Health Technology |
Morphotek, Inc.
Morphotek, Inc. Miscellaneous Commercial ServicesCommercial Services Morphotek, Inc. operates as a biotechnology company. It develops and distributes biopharmaceutical products. The firm leverages its Morphodoma and Libradoma platform technologies to develop and research a pipeline of preclinical and clinical stage monoclonal antibodies for the treatment of cancer, inflammation and infectious diseases. The company was founded by Nicholas C. Nicolaides, Luigi Grasso and Philip M. Sass in May 2000 and is headquartered in Exton, PA. | Commercial Services |
GSK Equity Investments Ltd.
GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity Investment Ltd (GSK Equity) is a venture capital firm a subsidiary of GlaxoSmithKline Plc founded in 1985. The firm is headquartered in Reedwood City, California. | Finance |
GlaxoSmithKline Biologicals NV
GlaxoSmithKline Biologicals NV BiotechnologyHealth Technology GlaxoSmithKline Biologicals SA manufactures vaccines for diseases such as hepatitis, influenza, rubella, and typhoid fever. Its activities include overall strategy, research and development, clinical trials, regulatory matters, production, quality control, marketing, and distribution. The company has partnership with WHO and UNICEF. GlaxoSmithKline Biologicals was founded in 1945 and is headquartered in Rixensart, Belgium. | Health Technology |
AlgoRx Pharmaceuticals, Inc.
AlgoRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AlgoRx Pharmaceuticals, Inc. was a pharmaceutical company. The company developed and commercialized drugs for pain management. The company was founded in 2001 and was hedquartered in Secaucus, NJ. | Health Technology |
Wave Life Sciences USA, Inc.
Wave Life Sciences USA, Inc. Electric UtilitiesUtilities Part of Wave Life Sciences Ltd., Wave Life Sciences USA, Inc. is a private company that provides nucleic acid therapeutics. The company is based in Cambridge, MA. The company was founded in 2012 by Gregory L. Verdine, Takeshi Wada. The CEO is Paul B. Bolno. | Utilities |